
CVS Health Corporation: updates and filings
Price
$88.59
November 16, 2026Market cap $113B
What Ploutos Investor adds for CVS Health
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
February 2026
November 2025
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Its own holdings as an investment manager (13F)Form13F-HR
- Nov 4, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Regulation FD disclosureForm8-K
- Nov 4, 2026Results of operationsForm8-K
- Aug 17, 2026Officer or director change, Regulation FD disclosureForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 6, 2026Its own holdings as an investment manager (13F)Form13F-HR
- Aug 5, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 5, 2026Results of operationsForm8-K
- Jun 23, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 22, 2026Shares registered for employeesFormS-8
- May 22, 2026Shelf registration for future offeringsFormS-3ASR
- May 18, 2026Officer or director change, shareholder voteForm8-K
- May 7, 2026Its own holdings as an investment manager (13F)Form13F-HR
- May 6, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 6, 2026Results of operationsForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 3, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 3, 2026Additional annual meeting materialFormDEFA14A
- Apr 3, 2026Annual meeting proxy statementFormDEF 14A
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 19, 2026Officer or director changeForm8-K
- Feb 13, 2026Its own holdings as an investment manager (13F)Form13F-HR
- Feb 10, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 10, 2026Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Aug 17, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 6, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| Aug 5, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 5, 2026 | 8-K | Results of operations | Document |
| Jun 23, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 22, 2026 | S-8 | Shares registered for employees | Document |
| May 22, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| May 18, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| May 7, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| May 6, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 6, 2026 | 8-K | Results of operations | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 3, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 3, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 3, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 19, 2026 | 8-K | Officer or director change | Document |
| Feb 13, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| Feb 10, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 10, 2026 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 10, 1994: every report, 8-K, meeting and letter. Of its other filings (1,123 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 80.
The full analysis
What do CVS Health's filings show?
The filings are where every one of CVS Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.